澳股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

MICROBA LIFE SCIENCES LTD

0.054

-0.002-3.57%

成交量：6.82萬

成交額：3,681

市值：3,872.43萬

市盈率：-1.57

高：0.054

開：0.054

低：0.054

收：0.056

52周最高：0.105

52周最低：0.036

股本：7.17億

流通股本：2.86億

量比：10.64

換手率：0.02%

股息：- -

股息率：- -

每股收益(TTM):-0.034

每股收益(LYR):-0.034

淨資產收益率：-72.87%

總資產收益率：-29.09%

市淨率：1.59

市盈率(LYR):-1.57

資料載入中...

總覽公司新聞公告

Microba生命科學：本財務期間未派發、建議或宣告任何股息

基因標記公司：合併集團有望憑藉精簡成本基礎與潛在加速增長受益

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/MAP.AU/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"MAP.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MAP.AU\",,,,,undefined,":{"symbol":"MAP.AU","market":"AU","secType":"STK","nameCN":"MICROBA LIFE SCIENCES LTD","latestPrice":0.054,"timestamp":1789366320000,"preClose":0.056,"halted":0,"volume":68172,"delay":0,"changeRate":-0.03571428571428575,"nameEN":"MICROBA LIFE SCIENCES LTD","floatShares":285729013,"shares":717117274,"eps":-0.034499,"marketStatus":"已收盤","change":-0.002,"latestTime":"09-14 16:12:00 AEST","open":0.054,"high":0.054,"low":0.054,"amount":3681,"amplitude":0,"askPrice":0.054,"askSize":131828,"bidPrice":0.05,"bidSize":910416,"shortable":3,"etf":0,"ttmEps":-0.034499,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1789430400000},"marketStatusCode":5,"adr":0,"listingDate":1648994400000,"exchange":"ASX","adjPreClose":0.056,"openAndCloseTimeList":[[1789344000000,1789365600000]],"volumeRatio":10.638909,"lotSize":0,"tradeCurrency":"AUD","auctionPricing":{"symbol":"MAP.AU","preClose":0.055,"auctionPrice":0.054,"auctionVolume":72157,"auction":3,"marketStatus":"盘后竞价","timestamp":1788156251123}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MAP.AU\",,,,,undefined,":{"symbol":"MAP.AU","floatShares":285729013,"roa":"-29.09%","roe":"-72.87%","lyrEps":-0.0345,"volumeRatio":10.638909,"shares":717117274,"dividePrice":0,"high":0.054,"amplitude":0,"preClose":0.056,"low":0.054,"week52Low":0.036,"pbRate":"1.59","psRate":"2.62","week52High":0.105,"institutionHeld":0,"latestPrice":0.054,"committee":0.74703,"eps":-0.034499,"divideRate":0,"volume":68172,"delay":0,"ttmEps":-0.034499,"open":0.054,"prevYearClose":0.076,"prevWeekClose":0.056,"prevMonthClose":0.054,"prevQuarterClose":0.036,"fiveDayClose":0.055,"twentyDayClose":0.054,"sixtyDayClose":0.039,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MAP.AU\",params:#limit:5,,,undefined,":[{"date":"2026-07-15","symbol":"MAP.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1784073600000,"name":null,"time":"","dateTimestamp":1784037600000,"actualEps":null},{"date":"2026-04-29","symbol":"MAP.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1777420800000,"name":null,"time":"","dateTimestamp":1777384800000,"actualEps":null},{"date":"2026-01-28","symbol":"MAP.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1769554800000,"name":null,"time":"","dateTimestamp":1769518800000,"actualEps":null},{"date":"2025-10-27","symbol":"MAP.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1761519600000,"name":null,"time":"","dateTimestamp":1761483600000,"actualEps":null},{"market":"AU","date":"2025-07-22","symbol":"MAP.AU","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1753106400000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MAP.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MAP.AU\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1126167867","title":"Microba生命科學：本財務期間未派發、建議或宣告任何股息","url":"https://stock-news.laohu8.com/highlight/detail?id=1126167867","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126167867?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 10:37","pubTimestamp":1788143832,"startTime":"0","endTime":"0","summary":"Microba生命科学（MICROBA LIFE SCIENCES LTD）在当前的财务报告期内，既未向股东派发股息，也未建议或宣告任何形式的股息分配方案。这一消息意味着，该公司在本阶段的利润分配策略上保持谨慎姿态，未动用留存收益进行分红。对于关注股东回报的投资者而言，此举或反映出公司在资金运用上的保守取向，亦可能为未来的资本开支或运营储备留出空间。整体来看，该公司在本次财务周期内完全规避了股息的支付与宣告流程，延续了零分红的政策基调。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAP.AU","BK7124"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125560310","title":"基因標記公司：合併集團有望憑藉精簡成本基礎與潛在加速增長受益","url":"https://stock-news.laohu8.com/highlight/detail?id=1125560310","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125560310?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 07:36","pubTimestamp":1787700997,"startTime":"0","endTime":"0","summary":"基因标记公司——合并后的集团预计将从精简的成本结构中获益，并可能迎来增长加速的契机。市场分析人士指出，成本基础的收窄不仅有助于提升盈利能力，更为潜在的扩张机遇创造了有利条件。值得注意的是，合并后实体的协同效应有望在中期内逐步显现，从而推动业绩增长轨迹向上修正。简而言之，这一变革性举措预示着集团将步入一个更加精简、高效且具备增长动能的新阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7124","GSS.AU","BK7501","BK7048","MAP.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}]}}